Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 901679, 9 pages
http://dx.doi.org/10.1155/2015/901679
Research Article

Death Receptor 3 (TNFRSF25) Increases Mineral Apposition by Osteoblasts and Region Specific New Bone Formation in the Axial Skeleton of Male DBA/1 Mice

1Institute of Infection and Immunity, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK
2University Hospital Llandough, Cardiff & Vale University Health Board, Cardiff CF64 2XX, UK

Received 17 October 2014; Revised 1 December 2014; Accepted 1 December 2014

Academic Editor: Giacomina Brunetti

Copyright © 2015 Fraser L. Collins et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Karsenty, H. M. Kronenberg, and C. Settembre, “Genetic control of bone formation,” Annual Review of Cell and Developmental Biology, vol. 25, pp. 629–648, 2009. View at Google Scholar
  2. S. L. Teitelbaum, “Osteoclasts: what do they do and how do they do it?” The American Journal of Pathology, vol. 170, no. 2, pp. 427–435, 2007, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851862/?tool=pmcentrez. View at Publisher · View at Google Scholar
  3. M. A. Khan, “Update on spondyloarthropathies,” Annals of Internal Medicine, vol. 136, no. 12, pp. 896–907, 2002. View at Google Scholar
  4. E. Dakwar, J. Reddy, F. L. Vale, and J. S. Uribe, “A review of the pathogenesis of ankylosing spondylitis,” Neurosurgical Focus, vol. 24, no. 1, p. E2, 2008. View at Publisher · View at Google Scholar
  5. P. Ory, “Radiography in the assessment of musculoskeletal conditions,” Best Practice & Research Clinical Rheumatology, vol. 17, no. 3, pp. 495–512, 2003. View at Publisher · View at Google Scholar
  6. E. Zinovieva, C. Bourgain, A. Kadi et al., “Comprehensive linkage and association analyses identify haplotype, near to the TNFSF15 gene, significantly associated with spondyloarthritis,” PLoS Genetics, vol. 5, no. 6, Article ID e1000528, 2009. View at Publisher · View at Google Scholar
  7. M. Konsta, G. Bamias, M. G. Tektonidou, P. Christopoulos, A. Iliopoulos, and P. P. Sfikakis, “Increased levels of soluble TNF-like cytokine 1A in ankylosing spondylitis,” Rheumatology, vol. 52, no. 3, pp. 448–451, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Schirmer, C. Goldberger, R. Würzner et al., “Circulating cytotoxic CD8+ CD28 T cells in ankylosing spondylitis,” Arthritis Research, vol. 4, no. 1, pp. 71–76, 2002. View at Google Scholar
  9. J. P. Twohig, M. Marsden, and S. M. Cuff, “The death receptor 3/TL1A pathway is essential for efficient development of antiviral CD4+ and CD8+ T-cell immunity,” The FASEB Journal, vol. 26, no. 8, pp. 3575–3586, 2012, http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3460213&tool=pmcentrez&rendertype=abstract. View at Publisher · View at Google Scholar
  10. R. Bu, C. W. Borysenko, Y. Li, L. Cao, A. Sabokbar, and H. C. Blair, “Expression and function of TNF-family proteins and receptors in human osteoblasts,” Bone, vol. 33, no. 5, pp. 760–770, 2003. View at Publisher · View at Google Scholar
  11. C. W. Borysenko, V. García-Palacios, R. D. Griswold et al., “Death receptor-3 mediates apoptosis in human osteoblasts under narrowly regulated conditions,” Journal of Cellular Physiology, vol. 209, no. 3, pp. 1021–1028, 2006. View at Google Scholar
  12. R. J. U. Lories, P. Matthys, K. De Vlam, I. Derese, and F. P. Luyten, “Ankylosing enthesitis, dactylitis, and onychoperiostitis in male DBA/1 mice: a model of psoriatic arthritis,” Annals of the Rheumatic Diseases, vol. 63, no. 5, pp. 595–598, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. E. C. Wang, A. Thern, A. Denzel, J. Kitson, S. N. Farrow, and M. J. Owen, “DR3 regulates negative selection during thymocyte development,” Molecular and Cellular Biology, vol. 21, no. 10, pp. 3451–3461, 2001. View at Google Scholar
  14. P. Robey and A. Boskey, “Extracellular matrix and biomineralisation of bone,” in Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, pp. 12–19, 2006. View at Google Scholar
  15. C. Filanti, G. R. Dickson, D. Di Martino et al., “The expression of metalloproteinase-2, -9, and -14 and of tissue inhibitors-1 and-2 is developmentally modulated during osteogenesis in vitro, the mature osteoblastic phenotype expressing metalloproteinase-14,” Journal of Bone and Mineral Research, vol. 15, no. 11, pp. 2154–2168, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Meylan, T. S. Davidson, E. Kahle, M. Kinder, K. Acharya, and D. Jankovic, “The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases,” Immunity, vol. 29, no. 1, pp. 79–89, 2008. View at Publisher · View at Google Scholar
  17. G. Bamias, M. Mishina, M. Nyce, W. G. Ross, G. Kollias, and J. Rivera-Nieves, “Role of TL1A and its receptor DR3 in two models of chronic murine ileitis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 22, pp. 8441–8446, 2006. View at Google Scholar
  18. T. J. Slebioda, T. F. Rowley, J. R. Ferdinand et al., “Triggering of TNFRSF25 promotes CD8+ T-cell responses and anti-tumor immunity,” European Journal of Immunology, vol. 41, no. 9, pp. 2606–2611, 2011. View at Publisher · View at Google Scholar
  19. T. Komori, H. Yagi, S. Nomura et al., “Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts,” Cell, vol. 89, no. 5, pp. 755–764, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Ducy, R. Zhang, V. Geoffroy, A. L. Ridall, and G. Karsenty, “Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation,” Cell, vol. 89, no. 5, pp. 747–754, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Nakashima, X. Zhou, G. Kunkel, Z. Zhang, J. M. Deng, and R. R. Behringer, “The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation,” Cell, vol. 108, no. 1, pp. 17–29, 2002. View at Publisher · View at Google Scholar
  22. Q. Shen and S. Christakos, “The vitamin D receptor, Runx2, and the Notch signaling pathway cooperate in the transcriptional regulation of osteopontin,” The Journal of Biological Chemistry, vol. 280, no. 49, pp. 40589–40598, 2005. View at Google Scholar
  23. C. K. Inman and P. Shore, “The osteoblast transcription factor Runx2 is expressed in mammary epithelial cells and mediates osteopontin expression,” The Journal of Biological Chemistry, vol. 278, no. 49, pp. 48684–48689, 2003, http://www.ncbi.nlm.nih.gov/pubmed/14506237. View at Publisher · View at Google Scholar
  24. Y.-J. Kang, W.-J. Kim, H.-U. Bae et al., “Involvement of TL1A and DR3 in induction of pro-inflammatory cytokines and matrix metalloproteinase-9 in atherogenesis,” Cytokine, vol. 29, no. 5, pp. 229–235, 2005. View at Google Scholar
  25. S. H. Kim, W. H. Lee, B. S. Kwon, G. T. Oh, Y. H. Choi, and J. E. Park, “Tumor necrosis factor receptor superfamily 12 may destabilize atherosclerotic plaques by inducing matrix metalloproteinases,” Japanese Circulation Journal, vol. 65, no. 2, pp. 136–138, 2001. View at Publisher · View at Google Scholar
  26. E. C. Y. Wang, Z. Newton, O. A. Hayward et al., “Regulation of early cartilage destruction in inflammatory arthritis by death receptor 3,” Arthritis & Rheumatology, vol. 66, no. 10, pp. 2762–2772, 2014. View at Publisher · View at Google Scholar
  27. S. L. Teitelbaum, “Bone resorption by osteoclasts,” Science, vol. 289, no. 5484, pp. 1504–1508, 2000. View at Google Scholar
  28. M. J. Bull, A. S. Williams, Z. Mecklenburgh et al., “The death receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis,” The Journal of Experimental Medicine, vol. 205, no. 11, pp. 2457–2464, 2008. View at Publisher · View at Google Scholar
  29. C.-H. Chen, H.-A. Chen, H.-T. Liao, C.-H. Liu, C.-Y. Tsai, and C.-T. Chou, “Soluble receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis: OPG is associated with poor physical mobility and reflects systemic inflammation,” Clinical Rheumatology, vol. 29, no. 10, pp. 1155–1161, 2010. View at Publisher · View at Google Scholar
  30. F. Cantini, L. Niccoli, C. Nannini, O. Kaloudi, M. Bertoni, and E. Cassarà, “Psoriatic arthritis: a systematic review,” International Journal of the Rheumatic Diseases, vol. 13, no. 4, pp. 300–317, 2010. View at Publisher · View at Google Scholar
  31. I. van Echteld, A. Cieza, A. Boonen et al., “Identification of the most common problems by patients with ankylosing spondylitis using the International Classification of Functioning, Disability and Health,” Journal of Rheumatology, vol. 33, no. 12, pp. 2475–2483, 2006. View at Google Scholar · View at Scopus